Molecular Infusions

Curated by Signal

Developer of cannabis-based therapeutics for multiple disorders

Overview

Developer of cannabis-based therapeutics for multiple disorders. It offers oral, inhalation, and topical-based cannabinoid formulation and delivery system for transformative cannabinoid therapies.

Key facts

Founded: 2016
Headquarters: Los Angeles, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

PediaMetrix
AI-based pediatric head measurement & monitoring tool
Health TechnologyRockville, United States
Prism Clinical
Products and services for managing the acquisition, post-processing and clinical viewing of advanced imaging studies
Health TechnologyBrookfield, United States
PelvicHEP
Online platform offering home-based exercises for pelvic fitness
Health TechnologyUnited States

About Molecular Infusions

What does Molecular Infusions do?

Developer of cannabis-based therapeutics for multiple disorders.

Where is Molecular Infusions headquartered?

Molecular Infusions is headquartered in Los Angeles, United States.

When was Molecular Infusions founded?

Molecular Infusions was founded in 2016.

Which sector is Molecular Infusions in?

Molecular Infusions operates in Health Technology.

Who are Molecular Infusions's competitors?

Companies similar to Molecular Infusions include PediaMetrix, Prism Clinical, and PelvicHEP.